Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

Gut microbiota / Evidence-based microbiome knowledge (incl. AI chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Biﬁdobacterium breve

Welcome to meRfi-GM!

Please register to continue your trial period!

meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

B. breve belongs to the species in the healthy human gut - the abundance is low: about 0.01% of all species in the healthy human gut
King et al. 2019

It increases Treg- and decrease Th17-cells
Zeng et al. 2019 J. Immunol. Res. 2019: 1603758

Presence of EPS positive Bifidobacterium breve reduced colonization levels of the gut pathogen Citrobacter rodentium
Fanning et al. 2012 PNAS 109(6): 2108-2113

…

References (Sources)

Baseline human gut microbiota profile in healthy people and standard reporting template
King et al. 2019
Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection
Fanning et al. 2012 PNAS 109(6): 2108-2113
Cutting Edge: Probiotics and Fecal Microbiota Transplantation in Immunomodulation
Zeng et al. 2019 J. Immunol. Res. 2019: 1603758
Review
Effects of the enteral administration of Bifidobacterium breve on patients undergoing chemotherapy for pediatric malignancies
Wada et al. 2010 Support Care Cancer 18(6): 751-9

AI Chat

12/17/2025

Chat with our artificial intelligence:

Start chat!

Biﬁdobacterium breve

Welcome to meRfi-GM!

Navigation

Contents

References (Sources)

AI Chat

Links